264 related articles for article (PubMed ID: 15978574)
1. Effect of vilazodone on 5-HT efflux and re-uptake in the guinea-pig dorsal raphe nucleus.
Roberts C; Hagan JJ; Bartoszyk GD; Kew JN
Eur J Pharmacol; 2005 Jul; 517(1-2):59-63. PubMed ID: 15978574
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
van Amsterdam C; Seyfried CA
Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
[TBL] [Abstract][Full Text] [Related]
3. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiological evidence for rapid 5-HT₁A autoreceptor inhibition by vilazodone, a 5-HT₁A receptor partial agonist and 5-HT reuptake inhibitor.
Ashby CR; Kehne JH; Bartoszyk GD; Renda MJ; Athanasiou M; Pierz KA; Seyfried CA
Eur J Pharmacol; 2013 Aug; 714(1-3):359-65. PubMed ID: 23872377
[TBL] [Abstract][Full Text] [Related]
5. SB-272183, a selective 5-HT(1A), 5-HT(1B) and 5-HT(1D) receptor antagonist in native tissue.
Watson J; Roberts C; Scott C; Kendall I; Collin L; Day NC; Harries MH; Soffin E; Davies CH; Randall AD; Heightman T; Gaster L; Wyman P; Parker C; Price GW; Middlemiss DN
Br J Pharmacol; 2001 Jul; 133(6):797-806. PubMed ID: 11454652
[TBL] [Abstract][Full Text] [Related]
6. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
[TBL] [Abstract][Full Text] [Related]
7. 5-HT1D as well as 5-HT1A autoreceptors modulate 5-HT release in the guinea-pig dorsal raphé nucleus.
Starkey SJ; Skingle M
Neuropharmacology; 1994; 33(3-4):393-402. PubMed ID: 7984277
[TBL] [Abstract][Full Text] [Related]
8. Do 5-HT1B/1D autoreceptors modulate dorsal raphe cell firing? In vivo electrophysiological studies in guinea pigs with GR127935.
Sprouse J; Reynolds L; Rollema H
Neuropharmacology; 1997; 36(4-5):559-67. PubMed ID: 9225281
[TBL] [Abstract][Full Text] [Related]
9. Effects of 8-OHDPAT and 5-HT1A antagonists WAY100135 and WAY100635, on guinea-pig behaviour and dorsal raphe 5-HT neurone firing.
Mundey MK; Fletcher A; Marsden CA
Br J Pharmacol; 1996 Feb; 117(4):750-6. PubMed ID: 8646424
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe.
Dong J; De Montigny C; Blier P
Synapse; 1999 Dec; 34(4):277-89. PubMed ID: 10529722
[TBL] [Abstract][Full Text] [Related]
11. Consequences of 5-HT re-uptake blockade on postsynaptic 5-HT1A receptor activation: an electrophysiological and neurochemical study in guinea pig dorsal raphe and hippocampus.
Sprouse J; Braselton J; Reynolds L; Clarke T; Rollema H
Ann N Y Acad Sci; 1998 Dec; 861():272-3. PubMed ID: 9928286
[No Abstract] [Full Text] [Related]
12. Activation of postsynaptic 5-HT(1A) receptors by fluoxetine despite the loss of firing-dependent serotonergic input: electrophysiological and neurochemical studies.
Sprouse J; Braselton J; Reynolds L; Clarke T; Rollema H
Synapse; 2001 Jul; 41(1):49-57. PubMed ID: 11354013
[TBL] [Abstract][Full Text] [Related]
13. In vivo efflux of serotonin in the dorsal raphe nucleus of 5-HT1A receptor knockout mice.
Bortolozzi A; Amargós-Bosch M; Toth M; Artigas F; Adell A
J Neurochem; 2004 Mar; 88(6):1373-9. PubMed ID: 15009637
[TBL] [Abstract][Full Text] [Related]
14. Effects of standardized extracts of St. John's wort on the single-unit activity of serotonergic dorsal Raphe neurons in awake cats: comparisons with fluoxetine and sertraline.
Fornal CA; Metzler CW; Mirescu C; Stein SK; Jacobs BL
Neuropsychopharmacology; 2001 Dec; 25(6):858-70. PubMed ID: 11750179
[TBL] [Abstract][Full Text] [Related]
15. SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue.
Scott C; Soffin EM; Hill M; Atkinson PJ; Langmead CJ; Wren PB; Faedo S; Gordon LJ; Price GW; Bromidge S; Johnson CN; Hagan JJ; Watson J
Eur J Pharmacol; 2006 Apr; 536(1-2):54-61. PubMed ID: 16571351
[TBL] [Abstract][Full Text] [Related]
16. Multiple 5-HT(1) autoreceptor subtypes govern serotonin release in dorsal and median raphé nuclei.
Hopwood SE; Stamford JA
Neuropharmacology; 2001 Mar; 40(4):508-19. PubMed ID: 11249960
[TBL] [Abstract][Full Text] [Related]
17. Serotonergic manipulations both potentiate and reduce brain stimulation reward in rats: involvement of serotonin-1A receptors.
Harrison AA; Markou A
J Pharmacol Exp Ther; 2001 Apr; 297(1):316-25. PubMed ID: 11259559
[TBL] [Abstract][Full Text] [Related]
18. EMD 68843, a serotonin reuptake inhibitor with selective presynaptic 5-HT1A receptor agonistic properties.
Bartoszyk GD; Hegenbart R; Ziegler H
Eur J Pharmacol; 1997 Mar; 322(2-3):147-53. PubMed ID: 9098681
[TBL] [Abstract][Full Text] [Related]
19. Roles of 5-HT(1A) receptors in the dorsal raphe and dorsal hippocampus in anxiety assessed by the behavioral effects of 8-OH-DPAT and S 15535 in a modified Geller-Seifter conflict model.
Cervo L; Mocaër E; Bertaglia A; Samanin R
Neuropharmacology; 2000 Apr; 39(6):1037-43. PubMed ID: 10727714
[TBL] [Abstract][Full Text] [Related]
20. Effects of 21 days treatment with fluoxetine on stimulated endogenous 5-hydroxytryptamine overflow in the rat dorsal raphe and suprachiasmatic nucleus studied using fast cyclic voltammetry in vitro.
O'Connor JJ; Kruk ZL
Brain Res; 1994 Mar; 640(1-2):328-35. PubMed ID: 8004461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
